Please enable JavaScript.
Coggle requires JavaScript to display documents.
J&J Studies (IBRUTINIB (Imbruvica) UNISUP 144-13-174 (NPE/LME) (144-14…
J&J Studies
IBRUTINIB
(Imbruvica) UNISUP
144-13-174
(NPE/LME)
144-14-226
-
SAKK 35/14
18900069 - Kit
Irbutinib/Placebo 140mg, 2 bottles of 120 grey capsules
18800793 - Ibrunitib Placebo
capsule, sealed box with 2 bottles of 120 grey capsules
18800794 - Ibrutinib 140mg
capsule, sealed box with 2 bottles of 120 grey capsules
:silhouettes:
Contacts
: Willemijn van der Horst, Chiara Secondini, Lisa Davenport
144-14-221
-
Triangle
144-13-202
-
CLL10 FLAIR
144-14-223
SAKK 36/13
CH
144-13-175
CCL12
[CRO]
:silhouettes:
Contact
: Amanda Brown
Actif + placebo + groupage actif & placebo
144-15-185
Kedmi
144-14-370
Enrich
ABIRATERONE
(Zytiga) UNISUP
144-11-031
(CVI/NPE)
144-13-048
144-11-074
-
STAMPEDE
144-13-007
SPARE-001AP 6711
144-13-022
-
212082PCR2031
144-13-077
-
212082PCR4010
144-17-144
- Zytiga (ModuProstate)
DARATUMUMAB
(2-8°C) UNISUP
144-15-110
(CVI/NPE)
1800mg
144-17-124
EMN14/54767414MMY3013 APOLLO Study
Spain
Turkey
Germany
The Netherlands
Italy
144-17-401
400mg
144-16-365
-
CA209-755
144-14-199
-
IFM MMY3006 - CASSIOPEIA
400mg
100mg
144-17-402
-
Dara 400mg 4 vials
144-17-310
-
Dara Fisher Switzerland
144-18-129
-
DART4MM - Gozetti IIS
400mg
100mg
144-18-204
-
Filo IDA53
144-15-110
144-17-102
REBUILD EAE-2017/MM01
144-17-103
DARE
VELCADE
(Bortezomib)
UNISUP
144-10-039
(CVI/NPE)
144-18-183
Team
144-16-493
-
MUK-9 Study
APALUTAMIDE
(ARN-09) UNISUP
144-15-161
(LME/NPE)
60 mg
144-18-156
CTOR18001 GZA
Belgium only - FR, NL, DE
144-18-158
Apalutamide 1531
144-16-314
-
FR label - Finished prod. CP/ID : 0012866
144-16-367
-
TAPS01
-
GB label - Finished prod. CP/ID : 0014804
POMALIDOMIDE